Hillary Clinton is urging federal regulators to go after an embattled pharma CEO who raised the price of a decades-old medication by 5,000 percent.
The Democratic front-runner wrote to the Food and Drug Administration and the Federal Trade Commission about the anti-parasite drug Daraprim, according to Reuters. The price of the generic drug rose from $13.50 to $750 after Turing Pharmaceuticals, led by 32-year-old former hedge fund manager Martin Shkreli, acquired the drug in August.
